Literature DB >> 26352111

Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay.

S C Sasson1, K McGill, L Wienholt, A Carr, D A Brown, A D Kelleher, S N Breit, W A Sewell.   

Abstract

Few reports have compared available serum free light chain (SFLC) assays. Here, a retrospective audit of the Freelite SFLC assay compared results to electrophoresis (EP)/immunofixation (IFX) and the N Latex FLC assay.A total of 244 samples collected over 3.5 months were studied using the Freelite and N Latex FLC nephelometry assays. Results were compared with serum and/or urine EP/IFX. The precision and linearity of the N Latex FLC assay was examined.Detectable paraprotein by serum or urine EP/IFX was present in 94% of samples with kappa and 100% with lambda FLC restriction. The correlation between the assays was higher for kappa (rho = 0.97) than lambda (rho = 0.89) especially when lambda results were above the upper limit of normal (rho = 0.62). Agreement in the categorical diagnosis as measured by the Cohen's kappa statistic was good (0.70). The N Latex FLC assay displayed good precision and linearity. In discordant samples the Freelite and N Latex FLC assays had equivalent agreement with IFX.Traditional methods of EP/IFX detected paraproteins in the majority of cases. Correlation between the Freelite and N Latex FLC assay is better for kappa than lambda FLC. The two assays are not entirely equivalent. Care should be taken by interpreting physicians and laboratories considering switching assays.

Mesh:

Substances:

Year:  2015        PMID: 26352111     DOI: 10.1097/PAT.0000000000000316

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  4 in total

1.  Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease.

Authors:  Yang Yang; Xiaoyan Han; Gaofeng Zheng; Zhen Cai
Journal:  Health Sci Rep       Date:  2019-02-05

2.  Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio.

Authors:  Gurmukh Singh
Journal:  J Clin Med Res       Date:  2016-11-24

3.  Analytical Criticalities Associated to Different Immunological Methods for Serum Free Light Chain Detection in Plasma Cell Dyscrasias: A Description of Particular Clinical Cases.

Authors:  Rocco Sabatino; Antonio Perrone; Marco Cuomo; Sandra Liotti; Vittoria Barchiesi; Monica Cantile; Ernesta Cavalcanti
Journal:  Int J Mol Sci       Date:  2017-04-12       Impact factor: 5.923

4.  Using Two Detection Methods to Observe the Changes and Significance of Free Light Chain in Serum and Urine in Patients with Renal Insufficiency.

Authors:  Lengnan Xu; Ban Zhao; Ying Sun; Songlan Wang; Xianguang Chen; Yonghui Mao
Journal:  Biomed Res Int       Date:  2022-03-29       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.